Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.012x

Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥110.78 Million ≈ $16.21 Million USD) by net assets (CN¥9.02 Billion ≈ $1.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)

Cash flow conversion efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. This chart illustrates how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tianjin Zhongxin Pharmaceutical Group Co (600329) stock price for real-time trading data and today's change.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Conversion Ratio Explained

Tianjin Zhongxin Pharmaceutical Group Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd ranked by their cash flow conversion efficiency. Also see market value of Tianjin Zhongxin Pharmaceutical Group Co for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Changsha Jingjia Microelectronics Co Ltd SHE:300474	-0.013x
Shenzhen Yan Tian Port Holdings Co Ltd SHE:000088	0.008x
Jiangsu Phoenix Publishing & Media Corp Ltd SHG:601928	0.031x
Strauss Group TA:STRS	0.114x
INDIVIOR PLC DL 050 F:2IVB	N/A
Amcor plc F:485	0.043x
QL Resources Bhd KLSE:7084	0.012x
JC Decaux SA PA:DEC	0.167x

Annual Cash Flow Conversion Efficiency for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. Review 600329 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.85 Billion ≈ $1.15 Billion	CN¥924.67 Million ≈ $135.31 Million	0.118x	+13.69%
2023-12-31	CN¥6.65 Billion ≈ $972.41 Million	CN¥688.49 Million ≈ $100.75 Million	0.104x	+0.23%
2022-12-31	CN¥6.55 Billion ≈ $958.76 Million	CN¥677.25 Million ≈ $99.10 Million	0.103x	-21.01%
2021-12-31	CN¥6.51 Billion ≈ $953.18 Million	CN¥852.40 Million ≈ $124.73 Million	0.131x	+15.96%
2020-12-31	CN¥5.95 Billion ≈ $870.66 Million	CN¥671.42 Million ≈ $98.25 Million	0.113x	+25.79%
2019-12-31	CN¥5.52 Billion ≈ $808.22 Million	CN¥495.49 Million ≈ $72.51 Million	0.090x	+29.50%
2018-12-31	CN¥5.05 Billion ≈ $739.62 Million	CN¥350.14 Million ≈ $51.24 Million	0.069x	+8165.98%
2017-12-31	CN¥4.63 Billion ≈ $676.85 Million	CN¥-3.97 Million ≈ $-581.32K	-0.001x	-100.88%
2016-12-31	CN¥4.30 Billion ≈ $629.56 Million	CN¥419.90 Million ≈ $61.44 Million	0.098x	+11.12%
2015-12-31	CN¥4.11 Billion ≈ $600.72 Million	CN¥360.58 Million ≈ $52.76 Million	0.088x	-9.77%
2014-12-31	CN¥2.95 Billion ≈ $431.19 Million	CN¥286.85 Million ≈ $41.98 Million	0.097x	+17.45%
2013-12-31	CN¥2.57 Billion ≈ $376.80 Million	CN¥213.44 Million ≈ $31.23 Million	0.083x	+807.71%
2012-12-31	CN¥2.28 Billion ≈ $333.46 Million	CN¥20.81 Million ≈ $3.04 Million	0.009x	-88.42%
2011-12-31	CN¥2.21 Billion ≈ $322.67 Million	CN¥173.88 Million ≈ $25.44 Million	0.079x	+18.36%
2010-12-31	CN¥2.09 Billion ≈ $305.38 Million	CN¥139.04 Million ≈ $20.35 Million	0.067x	+42.83%
2009-12-31	CN¥1.79 Billion ≈ $261.66 Million	CN¥83.41 Million ≈ $12.21 Million	0.047x	-55.90%
2008-12-31	CN¥1.47 Billion ≈ $215.50 Million	CN¥155.77 Million ≈ $22.79 Million	0.106x	+606.94%
2007-12-31	CN¥1.35 Billion ≈ $196.89 Million	CN¥20.13 Million ≈ $2.95 Million	0.015x	+175.03%
2006-12-31	CN¥1.41 Billion ≈ $206.07 Million	CN¥-28.08 Million ≈ $-4.11 Million	-0.020x	-114.84%
2005-12-31	CN¥1.95 Billion ≈ $285.17 Million	CN¥261.91 Million ≈ $38.33 Million	0.134x	+2304.03%
2004-12-31	CN¥1.88 Billion ≈ $274.74 Million	CN¥10.50 Million ≈ $1.54 Million	0.006x	-86.57%
2003-12-31	CN¥1.84 Billion ≈ $269.08 Million	CN¥76.57 Million ≈ $11.20 Million	0.042x	-62.51%
2002-12-31	CN¥1.69 Billion ≈ $247.19 Million	CN¥187.60 Million ≈ $27.45 Million	0.111x	+8.52%
2001-12-31	CN¥1.54 Billion ≈ $225.52 Million	CN¥157.73 Million ≈ $23.08 Million	0.102x	--

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.51 Billion

CN¥24.01 Billion CNY

Market Cap Rank

#4321 Global

#632 in China

Share Price

CN¥42.12

Change (1 day)

-0.85%

52-Week Range

CN¥34.04 - CN¥50.05

All Time High

CN¥54.12